Showing 1 - 10 of 53
When infrastructure meets AI
Oped, Bertrand Badré & Saurabh Mishra, Published on 16/01/2026
» Infrastructure investment is booming. Around the world, governments are pouring trillions of dollars into roads, power grids, data centres, water systems, and housing, with many responding to intensifying climate shocks and the growing need for adaptation. Yet the construction industry -- the single largest force physically reshaping the planet -- is among the last major sectors to unlock all the benefits that digital technology offers. As a result, it accounts for about 21% of greenhouse-gas emissions, produces half of global landfill waste, and overspends by US$1.6 trillion a year.
The rise of secondary destinations
Oped, Omri Morgenshtern, Published on 26/09/2025
» As we mark World Tourism Day tomorrow, we're turning the spotlight on one of the unsung heroes of travel -- secondary destinations. This international awareness day gives our industry an opportunity to take a pause and reflect on how travel is evolving. At Agoda, we see the growing popularity of secondary cities as a notable development in the travel market.
No Thatcher, is she
Oped, Postbag, Published on 28/07/2025
» Re: "Wartime requires a prime minister with full authority, (InQuote, July 25).
Unite to solve neglected diseases
Oped, Muhammad Radzi Abu Hassan, Published on 29/04/2025
» The successful collaboration between the health ministries of Malaysia and Thailand, industry partners in Egypt and Malaysia, and the Drugs for Neglected Diseases initiative (DNDi) to bring a new hepatitis C antiviral drug -- ravidasvir -- to market in 2022 was an important milestone. For years, a 12-week course of treatment using sofosbuvir cost between $70,000 (2.34 million baht) and $80,000, putting it out of reach for many in the Global South. But ravidasvir -- a safe and effective alternative when combined with sofosbuvir -- costs far less, averaging less than $500 per course.
Will Trump's trade war be a 2018 replay in Asia?
News, Manishi Raychaudhuri, Published on 21/03/2025
» While the unfolding tariff war has many similarities with Donald Trump's first trade skirmish in 2018 -- including levies on aluminium and steel and a "stop-go" trajectory -- that's where the resemblance ends.
Cheaper treatment
Oped, Postbag, Published on 11/02/2025
» Re: "Cancer patients are dying to survive", (Commentary, Feb 7).
Treatment protectionism
Postbag, Published on 09/02/2025
» Re: "Cancer patients dying to survive", (Opinion, Feb 7).
Cancer patients are dying to survive
News, Supara Janchitfah, Published on 07/02/2025
» As a university law lecturer, Nat is struggling to make ends meet. Her monthly salary of 33,000 baht is only a fraction of the cost of the super-expensive cancer drug she has been taking.
The world's babies need antibiotics
Oped, Glenda Gray, Published on 28/11/2024
» Over the last half-century, the number of children who die before reaching the age of five has fallen dramatically, from around 20 million in 1960 to 4.9 million in 2022, largely owing to the Expanded Programme on Immunisation (EPI). Established by the World Health Organization (WHO) in 1974, the EPI has been extraordinarily successful in providing the youngest people with access to vaccines, saving more than 150 million lives. But while such progress is worthy of celebration, there is still much work to do, because newborns comprise half of all deaths in children under five each year, many of which are caused by infection.